INTERNATIONAL PATENT: NANJING PROBIO BIOTECH CO., LTD., 南京蓬勃生物科技有限公司 FILES APPLICATION FOR "ANTIBODY TARGETING HUMAN CD7 OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF"

GENEVA, Feb. 3 -- NANJING PROBIO BIOTECH CO., LTD. (RM 4010, 28 Yongxi Road, Jiangning District (Jiangning High-tech Park)Nanjing, Jiangsu 211100), 南京蓬勃生物科技有限公司 (中国江苏省南京市江宁区雍熙路28号4010室(江宁高新园)) filed a patent application (PCT/CN2024/106402) for "ANTIBODY TARGETING HUMAN CD7 OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF" on Jul 19, 2024. With publication no. WO/2025/021027, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the Inte...